Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
71.03
-3.95 (-5.27%)
Mar 3, 2025, 4:00 PM EST - Market closed
Nuvalent Employees
Nuvalent had 92 employees as of December 31, 2023. The number of employees increased by 30 or 48.39% compared to the previous year.
Employees
92
Change (1Y)
30
Growth (1Y)
48.39%
Revenue / Employee
n/a
Profits / Employee
-$2,834,304
Market Cap
5.09B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 92 | 30 | 48.39% |
| Dec 31, 2022 | 62 | 22 | 55.00% |
| Dec 31, 2021 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
NUVL News
- 4 days ago - Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 7 weeks ago - Nuvalent Details Strategy to Seek First Potential Approval in 2026 and Outlines Key Anticipated 2025 Milestones - PRNewsWire
- 7 weeks ago - Nuvalent: A Logical Acquisition Target - Seeking Alpha
- 2 months ago - Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 3 months ago - Nuvalent Appoints Grant Bogle to Board of Directors - PRNewsWire
- 3 months ago - Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 3 months ago - Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results - PRNewsWire
- 5 months ago - Nuvalent: Promising Data Keeps Validating Pipeline And Platform - Seeking Alpha